2005-12-05: CIRCARE public comments to the Office for Human Research Protections Draft Guidance on Reporting and Reviewing Adverse Events and Unanticipated Problems. Available from http://www.circare.org/submit/ohrpdraftguidance_20051117.doc
2005-08-02: CIRCARE Presentation to the Secretary's Advisory Committee on Human Research Protection by Paul Gelsinger, CIRCARE Vice President. Available from http://www.circare.org/submit/sachrp_20050802.pdf
2005-04-18: CIRCARE Public Comments to the Secretary's Advisory Committee on Human Research Protection by Michael A. Susko, CIRCARE President. Available from http://www.circare.org/submit/sachrp_pubcom2005.pdf
2005-02-21: CIRCARE Testimony submitted to FDA Docket 2005N-0038 Public Meeting on Adverse Event Reporting to Institutional Review Boards. Available from http://www.circare.org/submit/FDA_Docket2005N-0038.pdf
Transcript of FDA Public Meeting on Adverse Event Reporting to Institutional Review Boards. 2005-03-21.
Transcript Part I. Available from http://www.fda.gov/ohrms/dockets/dockets/05n0038/05n-0038-tr00001-01-vol4.pdf
Transcript Part II. Available from http://www.fda.gov/ohrms/dockets/dockets/05n0038/05n-0038-tr00001-02-vol4.pdf
Transcript Part III. Available from http://www.fda.gov/ohrms/dockets/dockets/05n0038/05n-0038-tr00001-03-vol4.pdf
2003-07-09: CIRCARE Testimony before the Institute of Medicine panel on Clinical Research Involving Children by Paul Gelsinger, CIRCARE Vice President and Adil Shamoo Ph.D., CIRCARE Co-Founder. Available from http://www.iom.edu/includes/DBFile.asp?id=13801
Read all the testimony and associated material presented at this meeting and earlier meetings of the IOM panel on Clinical Research Involving Children:
Open Session Agenda Meeting of 2003-07-09. Available from http://www.iom.edu/subpage.asp?id=13665
Index of Meetings of the IOM Panel on Clinical Research Involving Children. Available from http://www.iom.edu/project.asp?id=4864
2002-04-23: CIRCARE Testimony submitted to the United States Senate Health, Education, Labor and Pensions Committee by Adil Shamoo Ph.D., CIRCARE Co-Founder and Michael A. Susko, CIRCARE President. Available from http://www.circare.org/230402Shamoo.pdf
2002-04-23: Testimony before the United States Senate Health, Education, Labor and Pensions Committee by Cherlynn Mathias R.N., CIRCARE Board of Directors. Available from http://www.circare.org/230402Ch.pdf
2002-04-03: CIRCARE Testimony in Support of Maryland House Bill 917 by Michael A. Susko, CIRCARE President. Available from http://www.circare.org/40302MSt.pdf
1999-04-21: CIRCARE Testimony before the Subcommittee on Oversight and Investigation, Committee on Veterans Affairs by Adil Shamoo Ph.D., CIRCARE Co-Founder, on The Unethical Use of Human Beings in High Risk Research Experiments. Available from http://www.house.gov /va/hearings/schedule106/apr99/4-21-99J/shamoo.htm
1998-04: CIRCARE Testimony before the House Committee on Government Reform by Adil Shamoo Ph.D., CIRCARE C0-Founder. Available from http://www.house.gov/ reform/hearings/healthcare/fda498/shamoo.pdf
1997-09-18: CIRCARE Testimony before the National Bioethics Commission Human Subjects Subcommittee. Available from http://bioethics. georgetown.edu/nbac/transcripts/sep97/human.pdf
Last Updated: 2007-04-01
If you find the information on this page helpful, please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page
All materials on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education. Adobe® Reader :: ::
